Working…
COVID-19 is an emerging, rapidly evolving situation.
Get the latest public health information from CDC: https://www.coronavirus.gov.

Get the latest research information from NIH: https://www.nih.gov/coronavirus.
ClinicalTrials.gov
ClinicalTrials.gov Menu

Copeptin as a Stress Marker During a Written Examination (CoEXAM)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT02051647
Recruitment Status : Completed
First Posted : January 31, 2014
Last Update Posted : December 4, 2014
Sponsor:
Information provided by (Responsible Party):
University Hospital, Basel, Switzerland

Brief Summary:
To investigate whether copeptin levels increase upon a psychological stress (i.e. written examination) and whether copeptin levels measured immediately before the written examination predict success of the examination.

Condition or disease
Healthy

Layout table for study information
Study Type : Observational
Actual Enrollment : 42 participants
Time Perspective: Prospective
Official Title: Copeptin as a Stress Marker During a Written Examination - the CoEXAM
Study Start Date : January 2014
Actual Primary Completion Date : September 2014
Actual Study Completion Date : September 2014

Resource links provided by the National Library of Medicine





Primary Outcome Measures :
  1. Change in copeptin levels upon examination stress comparing copeptin levels prior and after examination [ Time Frame: 4 hours ]

Secondary Outcome Measures :
  1. Correlation between copeptin levels prior to an exam and exam success [ Time Frame: 4 hours ]
  2. Correlation to cortisol as the classical stress marker [ Time Frame: 4 hours ]

Biospecimen Description:
Serum, Li-Heparin


Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   18 Years to 35 Years   (Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population
42 healthy voluntary medical students studying in the 4th year at Basel University
Criteria

Inclusion Criteria:

  • Age over 18 years
  • Member of 4th year in medical course at Basel University

Exclusion Criteria:

  • Intake of any medication (except birth control pill)
  • BMI over 30kg/m2
  • Evidence of acute disease
  • History of chronic illness, including chronic psychiatric disease
  • Anamnestic certain or assumed pregnancy
  • Regularly smoking students

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT02051647


Locations
Layout table for location information
Switzerland
University Hopsital Basel
Basel, Switzerland
Sponsors and Collaborators
University Hospital, Basel, Switzerland
Investigators
Layout table for investigator information
Principal Investigator: Mirjam Christ-Crain, Prof. University Hospital, Basel, Switzerland
Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):
Layout table for additonal information
Responsible Party: University Hospital, Basel, Switzerland
ClinicalTrials.gov Identifier: NCT02051647    
Other Study ID Numbers: 325/13
First Posted: January 31, 2014    Key Record Dates
Last Update Posted: December 4, 2014
Last Verified: December 2014
Keywords provided by University Hospital, Basel, Switzerland:
medical students
Basel University
Additional relevant MeSH terms:
Layout table for MeSH terms
Diabetes Insipidus
Kidney Diseases
Urologic Diseases
Pituitary Diseases
Endocrine System Diseases